Literature DB >> 25177076

Operational lessons drawn from pilot implementation of Xpert MTB/Rif in Brazil.

Betina Durovni1, Valeria Saraceni1, Marcelo Cordeiro-Santos2, Solange Cavalcante1, Elizabeth Soares1, Cristina Lourenço3, Alexandre Menezes4, Susan van den Hof5, Frank Cobelens6, Anete Trajman7.   

Abstract

PROBLEM: The World Health Organization has endorsed the Xpert MTB/RIF (Xpert), an automated polymerase-chain-reaction-based assay, for the rapid diagnosis of tuberculosis. However, large-scale use of a new technology calls for preparation and adaptation. APPROACH: A pilot implementation study was conducted in two Brazilian cities to explore the replacement of sputum smear microscopy with Xpert. The laboratories included covered 70% of the tuberculosis cases diagnosed, had no overlap in population catchment areas, handled different workloads and were randomly shifted to Xpert. Sputum samples were collected through the same routine procedures. Before the study the medical information system was prepared for the recording of Xpert results. Laboratory technicians were trained to operate Xpert machines and health workers were taught how to interpret the results. LOCAL
SETTING: The average annual tuberculosis incidence in Brazil is around 90 cases per 100,000 population. However, co-infection with the human immunodeficiency virus and multidrug resistance are relatively infrequent (10% and < 2%, respectively). RELEVANT CHANGES: Of the tested sputum samples, 7.3% were too scanty for Xpert and had to be examined microscopically. Ten per cent of Xpert equipment needed replacement, but spare parts were not readily available in the country. Absence of patient identification numbers led to the introduction of errors in the medical information system. LESSONS LEARNT: For nationwide scale-up, a local service provider is needed to maintain the Xpert system. Ensuring cartridge availability is also essential. The capacity to perform smear microscopy should be retained. The medical information system needs updating to allow efficient use of Xpert.

Entities:  

Mesh:

Year:  2014        PMID: 25177076      PMCID: PMC4147406          DOI: 10.2471/BLT.13.131409

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  9 in total

1.  Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis.

Authors:  Kai Chang; Weiping Lu; Junji Wang; Kejun Zhang; Shuangrong Jia; Fake Li; Shaoli Deng; Ming Chen
Journal:  J Infect       Date:  2012-02-27       Impact factor: 6.072

Review 2.  Systematic review: impact of health information technology on quality, efficiency, and costs of medical care.

Authors:  Basit Chaudhry; Jerome Wang; Shinyi Wu; Margaret Maglione; Walter Mojica; Elizabeth Roth; Sally C Morton; Paul G Shekelle
Journal:  Ann Intern Med       Date:  2006-04-11       Impact factor: 25.391

Review 3.  The benefits of health information technology: a review of the recent literature shows predominantly positive results.

Authors:  Melinda Beeuwkes Buntin; Matthew F Burke; Michael C Hoaglin; David Blumenthal
Journal:  Health Aff (Millwood)       Date:  2011-03       Impact factor: 6.301

4.  Bottlenecks and recommendations for the incorporation of new technologies in the tuberculosis laboratory network in Brazil.

Authors:  Maria Alice da Silva Telles; Alexandre Menezes; Anete Trajman
Journal:  J Bras Pneumol       Date:  2012 Nov-Dec       Impact factor: 2.624

Review 5.  Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.

Authors:  Karen R Steingart; Ian Schiller; David J Horne; Madhukar Pai; Catharina C Boehme; Nandini Dendukuri
Journal:  Cochrane Database Syst Rev       Date:  2014-01-21

6.  Rapid molecular detection of tuberculosis and rifampin resistance.

Authors:  Catharina C Boehme; Pamela Nabeta; Doris Hillemann; Mark P Nicol; Shubhada Shenai; Fiorella Krapp; Jenny Allen; Rasim Tahirli; Robert Blakemore; Roxana Rustomjee; Ana Milovic; Martin Jones; Sean M O'Brien; David H Persing; Sabine Ruesch-Gerdes; Eduardo Gotuzzo; Camilla Rodrigues; David Alland; Mark D Perkins
Journal:  N Engl J Med       Date:  2010-09-01       Impact factor: 91.245

7.  Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study.

Authors:  Catharina C Boehme; Mark P Nicol; Pamela Nabeta; Joy S Michael; Eduardo Gotuzzo; Rasim Tahirli; Ma Tarcela Gler; Robert Blakemore; William Worodria; Christen Gray; Laurence Huang; Tatiana Caceres; Rafail Mehdiyev; Lawrence Raymond; Andrew Whitelaw; Kalaiselvan Sagadevan; Heather Alexander; Heidi Albert; Frank Cobelens; Helen Cox; David Alland; Mark D Perkins
Journal:  Lancet       Date:  2011-04-18       Impact factor: 79.321

8.  Changes, disruption and innovation: An investigation of the introduction of new health information technology in a microbiology laboratory.

Authors:  George Toouli; Andrew Georgiou; Johanna Westbrook
Journal:  J Pathol Inform       Date:  2012-04-18

9.  Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India.

Authors:  Neeraj Raizada; K S Sachdeva; Achuthan Sreenivas; Bhavin Vadera; R S Gupta; Malik Parmar; Shubhangi Kulsange; Ameet Babre; Rahul Thakur; Christen Gray; Ranjani Ramachandran; Umesh Alavadi; Mayank Ghedia; Balasangameshwara Vollepore; Puneet Dewan; Catharina Boehme; C N Paramsivan
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

  9 in total
  5 in total

1.  The impact of the roll-out of rapid molecular diagnostic testing for tuberculosis on empirical treatment in Cape Town, South Africa.

Authors:  Sabine Hermans; Judy Caldwell; Richard Kaplan; Frank Cobelens; Robin Wood
Journal:  Bull World Health Organ       Date:  2017-04-28       Impact factor: 9.408

2.  Implementation of the Xpert MTB/RIF assay for tuberculosis in Mongolia: a qualitative exploration of barriers and enablers.

Authors:  Nicole L Rendell; Solongo Bekhbat; Gantungalag Ganbaatar; Munkhjargal Dorjravdan; Madhukar Pai; Claudia C Dobler
Journal:  PeerJ       Date:  2017-07-14       Impact factor: 2.984

Review 3.  A scoping review on the field validation and implementation of rapid diagnostic tests for vector-borne and other infectious diseases of poverty in urban areas.

Authors:  Lyda Osorio; Jonny Alejandro Garcia; Luis Gabriel Parra; Victor Garcia; Laura Torres; Stéphanie Degroote; Valéry Ridde
Journal:  Infect Dis Poverty       Date:  2018-09-03       Impact factor: 4.520

4.  Impact of replacing smear microscopy with Xpert MTB/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trial.

Authors:  Betina Durovni; Valeria Saraceni; Susan van den Hof; Anete Trajman; Marcelo Cordeiro-Santos; Solange Cavalcante; Alexandre Menezes; Frank Cobelens
Journal:  PLoS Med       Date:  2014-12-09       Impact factor: 11.069

5.  Shortened first-line TB treatment in Brazil: potential cost savings for patients and health services.

Authors:  Anete Trajman; Mayara Lisboa Bastos; Marcia Belo; Janaína Calaça; Júlia Gaspar; Alexandre Martins Dos Santos; Camila Martins Dos Santos; Raquel Trindade Brito; William A Wells; Frank G Cobelens; Anna Vassall; Gabriela B Gomez
Journal:  BMC Health Serv Res       Date:  2016-01-22       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.